Patent · US Expired

2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors

US6844335B2 · kind B2 · utility

8Cited by

1References

4Claims

0Family size

Assignees

Sanofi-Synthelabo · FR
MITSUBISHI PHARMA CORPORATION · JP

Inventors

Antonio Almario Garcia · Paris, FR
Ryoichi Ando · Yokohama, JP
Keiichi Arimoto · Tokyo, JP
Fumiaki Uehara · Tamamura, JP
Adrien Tak Li · Fontenay-aux-Roses, FR
Aya Shoda · Tokyo, JP
Jonathan R. Frost · Wissous, FR
Kazutoshi Watanabe · Tokyo, JP

Key dates

Filing date	Mar 22, 2001
Grant date	Jan 18, 2005
Priority date	—
Expiry date	May 29, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pyrimidone derivative represented by formula (I) or a salt thereof: And a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β such as Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.